GlaxoSmithKline hits 20% upper circuit on posting 400% jump in Q3 PAT

The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago

amazon
amazon
Ajai Shukla
2 min read Last Updated : Feb 17 2025 | 2:04 PM IST
GlaxoSmithKline Pharmaceuticals shares hit 20 per cent upper circuit in trade on BSE at Rs 2,421.3 per share. The buying on the counter came after the company posted its Q3 results. 
 
Around 9:52 AM, GlaxoSmithKline share price was up 19.35 per cent at Rs 2,408.25 per share on BSE. In comparison, the BSE Sensex was down 0.60 per cent at 75,485.33. The market capitalisation of the company stood at Rs 40,843.79 crore. The 52-week high of the stock was at Rs 3,087.95 per share and the 52-week low of the stock was at Rs 1,825.05 per share.
 
Glaxosmithkline Pharma reported its Q3 results on Friday before few minutes of market closing. The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago. The company's revenue for the quarter under review stood at 949.42 crore as against Rs 805.26 crore, rise of 17.9 per cent. 
 
The quarter saw strong performance across key product portfolios, the filing read. It added: Flagship brands within the general medicines portfolio including Augmentin, Ceftum, and T-bact strengthened their market positions with share gains. The company’s innovative Respiratory portfolio, led by Nucala and Trelegy, achieved robust growth, further expanding patient access across India.
Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

SAVE 25%

More From This Section

Topics :Adani Solar

First Published: Feb 17 2025 | 2:04 PM IST

Next Story